Amanda Tyler
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Immunology top 10%
- interferon and immune responses
- Immune responses and vaccinations
Papers in
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 3
-
- interferon and immune responses 3
- Partner nations
- United Kingdom
In The Last Decade
Amanda Tyler
6 papers receiving 1.2k citations
Amanda Tyler's Hit Papers
Peers
Comparison fields: 5 of 93
- Infectious Diseases 480
- Immunology 246
- Neurology 142
- Pulmonary and Respiratory Medicine 214
- Genetics 175
Countries citing papers authored by Amanda Tyler
This map shows the geographic impact of Amanda Tyler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Tyler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Tyler more than expected).
Fields of papers citing papers by Amanda Tyler
This network shows the impact of papers produced by Amanda Tyler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Tyler. The network helps show where Amanda Tyler may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 641 |
| 2 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 228 |
| 3 | Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy Hit paper breakdown → | 2021 | 190 |
| 4 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 121 |
| 5 | 2023 | 56 | |
| 6 | 2024 | 8 |
About Amanda Tyler
Amanda Tyler is a scholar working on Infectious Diseases, Immunology, Genetics, Epidemiology and Cell Biology, having authored 6 papers that have together received 1.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), interferon and immune responses (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Pneumonia and Respiratory Infections (1 paper), Liver Disease Diagnosis and Treatment (1 paper), Respiratory viral infections research (1 paper), Diabetes and associated disorders (1 paper) and Genetic Associations and Epidemiology (1 paper). The work is most often cited by research in Infectious Diseases (480 citations), Immunology (246 citations), Neurology (142 citations), Pulmonary and Respiratory Medicine (214 citations) and Genetics (175 citations). Amanda Tyler has collaborated with scholars based in United Kingdom. Their work appears in journals such as Nature, The Lancet and Human Genetics and Genomics Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.